| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.07B | 1.06B | 1.08B | 947.85M | 983.11M | 839.99M |
| Gross Profit | 329.48M | 314.44M | 311.94M | 260.99M | 261.92M | 268.94M |
| EBITDA | 4.11M | 7.03M | 34.97M | 20.71M | 28.77M | 81.85M |
| Net Income | -32.13M | -19.93M | 6.21M | 4.49M | 14.02M | 65.82M |
Balance Sheet | ||||||
| Total Assets | 901.55M | 875.45M | 773.33M | 789.36M | 717.96M | 665.11M |
| Cash, Cash Equivalents and Short-Term Investments | 48.95M | 61.32M | 38.18M | 90.50M | 17.93M | 77.17M |
| Total Debt | 263.90M | 267.62M | 230.80M | 243.87M | 197.72M | 182.46M |
| Total Liabilities | 696.14M | 661.17M | 541.50M | 567.71M | 485.50M | 438.40M |
| Stockholders Equity | 205.41M | 214.28M | 231.79M | 221.65M | 232.46M | 226.71M |
Cash Flow | ||||||
| Free Cash Flow | 5.64M | 19.37M | 4.84M | 18.71M | -3.62M | 12.18M |
| Operating Cash Flow | 74.05M | 88.80M | 42.89M | 58.60M | 54.30M | 110.97M |
| Investing Cash Flow | -64.69M | -92.83M | -60.86M | -8.34M | -83.36M | -116.84M |
| Financing Cash Flow | -32.28M | 22.89M | -32.58M | 26.67M | -32.72M | 68.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | HK$707.01M | 6.07 | 20.67% | 8.08% | 25.95% | 44.12% | |
| ― | HK$1.16B | 8.78 | 3.36% | 7.24% | -5.37% | 25.20% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | HK$713.36M | -24.58 | -1.52% | 5.85% | 0.37% | -331.54% | |
| ― | HK$390.26M | ― | -8.05% | ― | -24.13% | -27.54% | |
| ― | HK$564.55M | ― | -14.53% | ― | 0.35% | -153.95% | |
| ― | HK$139.00M | ― | -15.93% | ― | -25.21% | 12.04% |
SANVO Fine Chemicals Group Limited announced its unaudited consolidated results for the first half of 2025, highlighting the company’s compliance with the Hong Kong Stock Exchange’s listing rules. The interim report will be accessible on the company’s website and the Stock Exchange’s website, providing stakeholders with detailed insights into the company’s performance.
The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.
SANVO Fine Chemicals Group Limited has issued a profit warning, expecting to record a loss of approximately RMB11.4 million for the six months ended June 30, 2025. This marks a significant increase in losses compared to the same period in 2024, primarily due to heightened marketing, advertising, and promotion expenses.
The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.
SANVO Fine Chemicals Group Limited has announced a board meeting scheduled for August 29, 2025, to approve the interim results for the first half of the year and consider an interim dividend. This meeting could potentially impact the company’s financial performance and shareholder returns, reflecting its ongoing business strategies and market positioning.
The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.